IV Vitamin C: What Cancer Recovery Research Reveals About Fatigue, Recovery, and Quality of Life
IV vitamin C delivers ascorbic acid directly into the bloodstream. Researchers have studied it as supportive care for people with cancer, including those struggling with fatigue during treatment. Some patients have reported feeling better, but evidence for using a vitamin drip to improve a healthy athlete’s recovery remains limited.

In this article
What changes when vitamin C is given by IV?
Vitamin C helps the body make collagen, carnitine and certain neurotransmitters. It also acts as an antioxidant. People need it in their diet, and severe deficiency can cause fatigue and connective-tissue problems. The NIH Office of Dietary Supplements explains these everyday roles.
The gut regulates how much vitamin C is absorbed, while the kidneys remove excess vitamin C in urine. An infusion bypasses intestinal absorption and produces much higher blood concentrations. That difference is why researchers investigate IV vitamin C as a medical treatment. A higher blood concentration, by itself, tells us little about how someone will feel or perform.
What have cancer patients reported?
Cancer-related fatigue can affect physical activity, concentration and daily life. Researchers often use questionnaires that ask about symptoms and the ability to carry out ordinary activities.
In a 2007 prospective study, Yeom and colleagues followed 39 people with terminal cancer who were not receiving chemotherapy. Participants received IV and oral vitamin C during the study. Their average global health and quality-of-life score rose from 36 to 55, and they reported less fatigue, pain, nausea and appetite loss. Everyone received vitamin C; without a comparison group, the study could not separate its effect from other changes during care.
A 2012 observational study by Takahashi and colleagues followed 60 people with cancer through four weeks of treatment. Some were also receiving chemotherapy. The researchers reported improvements in fatigue and quality-of-life scores. This was another small observational study, rather than a placebo-controlled trial.
Individual experiences also helped draw researchers’ attention. Carr, Vissers and Cook described a woman receiving weekly chemotherapy for recurrent breast cancer whose fatigue and insomnia improved during IV vitamin C treatment. Their 2014 case report recorded cognitive improvement as well.
In their 2014 review, the same researchers also described an 81-year-old man with inoperable pulmonary angiosarcoma. After seven consecutive days of IV vitamin C, his questionnaires recorded lower fatigue and improved quality of life. These reports capture what happened to two patients; a case report cannot tell a treating team how reliably another patient will respond.
The review recalled the question that had motivated earlier work:
“Any agent which can make, or even appear to make, the burden of terminal cancer more tolerable, deserves further study.” — Early vitamin C researchers on quality of life improvements
Relieving a person’s burden during cancer treatment is a worthwhile research goal. It is a different clinical problem from recovering between training sessions.
What does fatigue research mean for an athlete?
A placebo-controlled trial offers a useful example outside oncology. Suh and colleagues’ 2012 study analyzed 141 healthy office workers aged 20–49. They received either one IV vitamin C treatment or saline. Ratings of fatigue at that moment improved in the vitamin C group at two hours and remained lower the following day. Ratings of usual fatigue and worst fatigue over the previous day did not differ between groups.
The study followed subjective tiredness for one day, rather than recovery from a workout or athletic performance. Its subgroup analysis suggested that people starting with lower vitamin C levels responded more than those with higher levels. That makes a person’s nutritional status an important question, rather than a reason to choose an infusion from a recovery menu.
Exercise research also gives a more complicated picture than the idea that more antioxidants mean better training. The NIH exercise-supplement fact sheet describes trials in which large oral doses of vitamins C and E reduced some cellular adaptations to training. Those were oral combination supplements, not IV vitamin C. For an athlete, meeting nutritional needs and assessing the actual training outcome matter more than assuming a stronger antioxidant effect will help.
Is IV vitamin C safe?
Medical screening matters. The National Cancer Institute’s clinical summary describes generally good tolerability in screened trial participants, alongside reports of kidney injury in people with pre-existing kidney disorders and a risk of red-blood-cell breakdown in people with G6PD deficiency. High-dose IV vitamin C can also interfere with some glucose-meter readings.
For a person receiving cancer treatment, any proposed infusion belongs in a conversation with the oncology team because interactions depend on the treatment involved. The FDA has not approved high-dose vitamin C as a cancer treatment.
Trials have also examined IV vitamin C alongside chemotherapy. For example, a small ovarian-cancer study reported fewer lower-grade treatment toxicities. These combination studies concern particular drugs and patients; their findings need to be interpreted within that treatment setting.
What should you do about ongoing fatigue?

Start with what has changed: training demands, meals, sleep, stress or illness. Keep a simple record of when fatigue occurs and how it affects daily activity. If it persists despite enough sleep and good nutrition, MedlinePlus advises an evaluation by a healthcare professional. Treatment depends on the cause.
A sports dietitian can help assess food intake and whether a nutrient gap needs attention. In USA Track & Field’s guidance on IV infusions, USADA science director Laura Lewis emphasizes food and appropriate medical care for athletes, rather than routine vitamin drips.
Athletes subject to anti-doping rules should also check an infusion with their anti-doping organization and tell their treating clinician about those rules. The USADA checklist addresses the substance, fluid volume, medical setting and circumstances in which a therapeutic use exemption may be needed.
Vitamin C deserves a place in a varied diet. An IV appointment is a medical decision that should follow an assessment of the person and the problem they are trying to solve.
References
Yeom, C. H., Jung, G. C., & Song, K. J. (2007). Changes of terminal cancer patients’ health-related quality of life after high dose vitamin C administration. Journal of Korean Medical Science, 22(1), 7–11. Primary study.
Takahashi, H., Mizuno, H., & Yanagisawa, A. (2012). High-dose intravenous vitamin C improves quality of life in cancer patients. Personalized Medicine Universe, 1(1), 49–53. Primary study.
Carr, A. C., Vissers, M. C. M., & Cook, J. (2014). Relief from cancer chemotherapy side effects with pharmacologic vitamin C. New Zealand Medical Journal, 127(1388), 66–70. Case report.
Carr, A. C., Vissers, M. C. M., & Cook, J. S. (2014). The effect of intravenous vitamin C on cancer- and chemotherapy-related fatigue and quality of life. Frontiers in Oncology, 4, 283. Review and historical case context.
Suh, S.-Y., et al. (2012). Intravenous vitamin C administration reduces fatigue in office workers: a double-blind randomized controlled trial. Nutrition Journal, 11, 7. Primary study.
National Cancer Institute. Intravenous Vitamin C (PDQ), Health Professional Version.
NIH Office of Dietary Supplements. Vitamin C; Dietary Supplements for Exercise and Athletic Performance.
MedlinePlus. Fatigue.
Lewis, L. (2025). 5 Things to Know About IV Rehydration and Vitamin Infusions. USA Track & Field / TrueSport.
U.S. Anti-Doping Agency. IV Injection and Infusion Checklist.
